Who was studied?
A 65-year-old man with recurrent metastatic penile squamous cell carcinoma progressing after chemotherapy.
What does the publication report?
The report describes tumor regression at treated and distant sites over 3 courses of PRaG.
Safety findings
The abstract describes mild side effects without a detailed graded breakdown.
How should we interpret it?
An uncontrolled case cannot determine how frequently an abscopal response occurs or isolate each treatment component.
Read the original source
This independently written summary was checked against the publicly available abstract. Selected figures, where included, are checked against the full publication. This is not a full-paper translation or a clinical recommendation.
PRaG Therapy for Advanced Penile Squamous Cell Carcinoma with Abscopal Effects: A Case Report · DOI: 10.54457/DR.202502003
Educational reporting, not individualized medical advice. Discuss treatment decisions with your clinical team.